Giovanni Cozzone

Rome Area, Italy, RM Italy

Co-Founder and CEO of Vaxxit Srl., Rome, Italy

Medical / Health Care / Pharmaceuticals

A New Hope for Africa, a Serious Market Opportunity Vaxxit Srl, of Rome, Italy (VXT) is raising €5 million to co-fund Phase III studies for registration of TatimmuneTM (scientific name: Tat vaccine), a proprietary new treatment for HIV/AIDS, in South Africa (SA). The Marketing Authorization in SA will accelerate clinical development and licensing in Europe and the USA. Data from SA are widely accepted by both agencies. HIV/AIDS is a huge problem in Africa, and in SA particularly. The SA Government spends over US$ 1.5 billion only for HIV drugs and will double that amount by 2020 to provide access to therapy to everybody infected. This effort is seriously damaged by high rates of drug fai...